SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 33.53-2.8%Nov 12 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (17083)8/18/2004 1:49:31 PM
From: Edscharp   of 17367
 
Cacaito,

My intuition tells me that this is pretty much the end for bpi. The one application it should've worked on was acne.

Xoma always had great success with bpi killing bacteria in the test tube (petri dish?). You can't swing a dead-cat without finding an abstract that demonstrates 'strong indications' that bpi is effective against gram negative bacteria, gram positive bacteria or gram crackers.

One would've supposed that bpi has a strong topical effect on acne bacteria, except I guess when worn by teenagers . Blame the sugar in the gram crackers I guess.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext